Application 065129
- Type
- ANDA
- Sponsor
- LUPIN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SUPRAX | CEFIXIME | FOR SUSPENSION;ORAL | 100MG/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68180-202 | SUPRAX | CEFIXIME | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-202 | SUPRAX | CEFIXIME | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-202 | SUPRAX | CEFIXIME | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-405 | CEFIXIME | CEFIXIME | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-405 | CEFIXIME | CEFIXIME | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-405 | CEFIXIME | CEFIXIME | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-416 | CEFIXIME | CEFIXIME | Lupin Pharmaceuticals, Inc. | ANDA | Current |